P2RY6 and asthma: In particular, the UDP-activated metabotropic receptor P2Y6 has been implicated in the regulation of myeloid cells, promoting type 2 functions, hyper-reactivity and immunosuppression in contexts such as experimental asthma and dust mite allergy in mice or autoimmune Graves’ disease in humans60–62.